| 标题 |
Switching to camizestrant at ESR1 mutation emergence before disease progression during first-line treatment of hormone receptor-positive advanced breast cancer (SERENA-6): extended analysis of a double-blind, placebo-controlled, randomised, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:Nicholas C Turner; Erica L. Mayer; Y. Park; W. Janni; Cynthia X Ma; et al 出版日期:2026-07-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)